About Cerecin
Cerecin is a company based in Singapore (Singapore) founded in 2001.. Cerecin has raised $265.68 million across 14 funding rounds from investors including Nestlé, KB Securities and Wilmar International. Cerecin operates in a competitive market with competitors including T3D Therapeutics, Alzheon, Longeveron, Alchemab and Totus Medicines, among others.
- Headquarter Singapore, Singapore
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$4.47 M (USD)-5as on Dec 31, 2021
-
Net Profit
$80.5 K (USD)-72as on Dec 31, 2021
-
EBITDA
-
Total Equity Funding
$265.68 M (USD)
in 14 rounds
-
Latest Funding Round
$3.74 M (USD), Series C
Jun 10, 2024
-
Investors
Nestlé
& 12 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Cerecin
Cerecin has successfully raised a total of $265.68M across 14 strategic funding rounds. The most recent funding activity was a Series C round of $3.74 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Series C — $3.7M
-
First Round
First Round
(05 Oct 2004)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Series C - Cerecin | Valuation |
investors |
|
| Aug, 2022 | Amount | Series C - Cerecin | Valuation | SK Securities |
|
| Oct, 2021 | Amount | Series C - Cerecin | Valuation | K&T Partners , Hana Financial Group |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cerecin
Cerecin has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Nestlé, KB Securities and Wilmar International. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
PE firm investing in South Korea and the US
|
Founded Year | Domain | Location | |
|
Investment solutions are provided by M Capital for various sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cerecin
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cerecin
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cerecin Comparisons
Competitors of Cerecin
Cerecin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as T3D Therapeutics, Alzheon, Longeveron, Alchemab and Totus Medicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for neurodegenerative diseases, including Alzheimer's, are developed.
|
|
| domain | founded_year | HQ Location |
Oral inhibitors of amyloid aggregation for Alzheimer's treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cellular therapies for aging-related and life-threatening conditions are developed.
|
|
| domain | founded_year | HQ Location |
Developer of antibody based therapeutics to treat cancers, neurodegenerative conditions and infectious diseases
|
|
| domain | founded_year | HQ Location |
Genome-scale drug discovery platform is provided for treating multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cerecin
Frequently Asked Questions about Cerecin
When was Cerecin founded?
Cerecin was founded in 2001 and raised its 1st funding round 3 years after it was founded.
Where is Cerecin located?
Cerecin is headquartered in Singapore, Singapore.
Is Cerecin a funded company?
Cerecin is a funded company, having raised a total of $265.68M across 14 funding rounds to date. The company's 1st funding round was a Series C of $30M, raised on Oct 05, 2004.
What is the annual revenue of Cerecin?
Annual revenue of Cerecin is $4.47M as on Dec 31, 2021.
What does Cerecin do?
Cerecin was founded in 2001 in Singapore and operates in the biotechnology sector focused on Alzheimers treatments. Medical foods containing ketone bodies and medium-chain triglycerides are developed to support memory and cognition. An oral formulation of aricaprilin, a medium-chain triglyceride that promotes ketosis and enhances mitochondrial metabolism, is also offered for Alzheimers management. Operations are centered in Singapore.
Who are the top competitors of Cerecin?
Cerecin's top competitors include Alzheon, Longeveron and Alchemab.
Who are Cerecin's investors?
Cerecin has 13 investors. Key investors include Nestlé, KB Securities, Wilmar International, SK Securities, and Hana Financial Group.